.Pharmacolibrary.Drugs.N_NervousSystem.N05C_HypnoticsAndSedatives.N05CF03_Zaleplon.Zaleplon .Pharmacolibrary.Drugs.N_NervousSystem.N05C_HypnoticsAndSedatives.N05CF03_Zaleplon.Zaleplon| name: | Zaleplon | |
| ATC code: | N05CF03 | route: | oral |
| compartments: | 1 | |
| dosage: | 10 | mg |
| volume of distribution: | 1.4 | L |
| clearance: | 3.9 | L/h/kg |
| other parameters in model implementation | ||
Zaleplon is a nonbenzodiazepine hypnotic agent used for the short-term treatment of insomnia. It acts as a selective agonist at the benzodiazepine site of the GABA-A receptor complex, enhancing GABAergic inhibition. Zaleplon is FDA-approved for use in adults with difficulty falling asleep, and is currently available in several countries.
Typical pharmacokinetic parameters in healthy adult volunteers, both sexes, after single oral dose.